Increasing the Ocrevus dose used in treating MS provided no additional benefit versus the approved regimen in trials with over 1,500 patients.

Following treatment with TG Therapeutics’ Briumvi, patients reported improvements in satisfaction and quality of life.

New diagnostic criteria for multiple sclerosis are helping doctors identify the disease sooner, allowing patients to begin ...

An experimental MS therapy given as a nasal spray has started dosing its final participant in a Phase 2a trial of people with ...

Key opinion leaders discuss the single FDA-approved option for primary progressive multiple sclerosis and emerging therapies under investigation for this MS subtype, examine the PERSEUS trial, and ...

The National Institute for Health and Care Excellence (NICE) has updated its guidance on the use of cladribine (Mavenclad, Merck) for patients with rapidly evolving severe relapsing-remitting multiple ...

A generation ago, most people with multiple sclerosis could expect to rely on walkers and wheelchairs or be limited to their bed within 15 years of diagnosis. Today, UC San Francisco’s discoveries are ...

Why does multiple sclerosis progress quickly in some people, while others remain stable for years? Researchers from the ...

Should multiple sclerosis (MS) patients stop disease-modifying treatment (DMT) as they get older? The answer depends on several factors, noted John Corboy, MD, of the Rocky Mountain MS Center at the ...

He revealed more recently he had bio-cellular therapy treatment on his spine Kevin Winter/Getty Jack Osbourne is opening up about his Multiple Sclerosis (MS) diagnosis. The 38-year-old media ...

Scientists have uncovered a surprising clue that may help explain why multiple sclerosis (MS) progresses rapidly in some people but not others. In brain tissue from patients with severe MS, ...